Kayyem Jon Faiz

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -18% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
11 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kayyem Jon Faiz's trades of Inhibrx Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
25.26
Quantity 9,500 -0.3%
Value US$239,999
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
27.61
Quantity 1,959 -0.1%
Value US$54,088
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
26.87
Quantity 7,541 -0.2%
Value US$202,591
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
30.12
Quantity 6,767 -0.2%
Value US$203,819
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
29.33
Quantity 2,733 -0.1%
Value US$80,153
Transaction date
Purchase
Price
1.15
Quantity 173,913 +inf%
Value US$200,000
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
30.58
Quantity 5,928 -0.2%
Value US$181,255
US Inhibrx Inc (INBX)
Transaction date
Planned sale
Price
29.39
Quantity 3,572 -0.1%
Value US$104,977
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-23 2026-09-23
B Purchase
45,791 +38.8%
356.91
US$2,294,880 		45,791 +38.8% 356.91 US$2,294,880
2026-09-17 2026-09-16
B Purchase
15,983 -12.3%
341.77
US$2,526,339 		15,983 -12.3% 341.77 US$2,526,339
2026-09-08 2026-09-08
B Purchase
79,066 -38.2%
391.42
US$2,979,081 		79,066 -38.2% 391.42 US$2,979,081
2024-11-22 2024-11-20
B Purchase
18,750 +36.7%
14.19
US$266,102 		18,750 +36.7% 14.19 US$266,102
2024-11-22 2024-11-20
B Purchase
18,750 +36.7%
14.19
US$266,102 		18,750 +36.7% 14.19 US$266,102
2024-11-22 2024-11-19
B Purchase
34,843 +214.4%
14.23
US$495,708 		34,843 +214.4% 14.23 US$495,708
2024-11-22 2024-11-19
B Purchase
34,843 +214.4%
14.23
US$495,708 		34,843 +214.4% 14.23 US$495,708
2024-06-07 2024-06-05
B Purchase
8,265 +0.7%
17.89
US$147,861 		8,265 +0.7% 17.89 US$147,861
2024-06-07 2024-06-05
B Purchase
49,284 +4.5%
17.23
US$849,163 		49,284 +4.5% 17.23 US$849,163
2024-06-04 2024-06-04
B Purchase
23,726 +2.2%
18.24
US$432,762 		23,726 +2.2% 18.24 US$432,762
2024-06-04 2024-06-04
B Purchase
65,337 +6.5%
17.44
US$1,139,477 		65,337 +6.5% 17.44 US$1,139,477
2024-06-04 2024-06-03
B Purchase
80,738 +8.7%
17.90
US$1,445,210 		80,738 +8.7% 17.90 US$1,445,210
2024-06-04 2024-06-03
B Purchase
46,792 +5.3%
16.61
US$777,215 		46,792 +5.3% 16.61 US$777,215
2024-06-04 2024-05-31
B Purchase
70,193 +8.7%
16.14
US$1,132,915 		70,193 +8.7% 16.14 US$1,132,915
2023-01-23 2023-01-23
US Inhibrx Inc (INBX)
PlS Planned sale
9,500 -0.3%
25.26
US$239,999 		9,500 -0.3% 25.26 US$239,999
2022-12-22 2022-12-21
US Inhibrx Inc (INBX)
PlS Planned sale
1,959 -0.1%
27.61
US$54,088 		1,959 -0.1% 27.61 US$54,088
2022-12-22 2022-12-21
US Inhibrx Inc (INBX)
PlS Planned sale
7,541 -0.2%
26.87
US$202,591 		7,541 -0.2% 26.87 US$202,591
2022-11-22 2022-11-21
US Inhibrx Inc (INBX)
PlS Planned sale
6,767 -0.2%
30.12
US$203,819 		6,767 -0.2% 30.12 US$203,819
2022-11-22 2022-11-21
US Inhibrx Inc (INBX)
PlS Planned sale
2,733 -0.1%
29.33
US$80,153 		2,733 -0.1% 29.33 US$80,153
2022-11-21 2022-11-21
B Purchase
173,913 +inf%
1.15
US$200,000 		173,913 +inf% 1.15 US$200,000
2022-10-24 2022-10-21
US Inhibrx Inc (INBX)
PlS Planned sale
5,928 -0.2%
30.58
US$181,255 		5,928 -0.2% 30.58 US$181,255
2022-10-24 2022-10-21
US Inhibrx Inc (INBX)
PlS Planned sale
3,572 -0.1%
29.39
US$104,977 		3,572 -0.1% 29.39 US$104,977